Moreyra A E, Carriquiriborde M, Mosca S M
UMDNI-Robert Wood Johnson Medical School, Department of Medicine/Division Cardiology, New Brunswick, USA.
Arch Physiol Biochem. 1996;104(3):265-71. doi: 10.1076/apab.104.3.265.12907.
The aim of the present study was to evaluate the effects of a single dose of nifedipine on myocardial stunning in isolated rabbit hearts. Hearts from rabbits pretreated with a single dose of 20 mg of nifedipine (NIF group) 1-4 h before isolation were compared to control hearts in their response to 15 min of global ischemia (37 degrees C) followed by 30 min of reperfusion. Both experimental groups showed similar baseline cardiac contractility. At the end of the reperfusion period in the control group, isovolumic left ventricular developed pressure (LVDP) and +dP/dtmax had stabilized at 45 +/- 2 and 48 +/- 2% of preischemic values respectively and in the NIF group LVDP stabilized at 63 +/- 6 and +dP/dtmax at 66 +/- 6% (P < 0.05 with respect to the control group). Left ventricular end diastolic pressure (LVEDP) values were significantly lower at the end of reperfusion in the NIF group compared to the controls (36.8 +/- 5.5 mmHg vs 53.4 +/- 3.9 mmHg, P < 0.05). The early impairment of the time constant of relaxation (tau) observed in control hearts was attenuated by pretreatment with nifedipine (control delta tau = 55 +/- 10 ms; NIF group delta tau = 29 +/- 5 ms, P < 0.05). Tissue ATP and creatine phosphate (CP) levels in the control group at the end of reperfusion were 6.9 +/- 0.7 and 8.7 +/- 0.7 mumol/g dry tissue, respectively; in the NIF group ATP and CP levels were significantly higher, 9.2 +/- 0.7 and 11.5 +/- 0.9 mumol/g dry tissue respectively (P < 0.05). Creatine kinase (CK) and lactate dehydrogenase (LDH) leakage during reperfusion were significantly higher in the control group (CK = 120 +/- 15 mU/ml and LDH = 60 +/- 8 mU/ml) compared to the NIF group (CK = 82 +/- 5 mU/ml and LDH = 41 +/- 2 mU/ml, P < 0.05). Our results demonstrate that pretreatment with a single oral dose (20 mg) of nifedipine attenuates systolic and diastolic functional alterations as well as the metabolic impairment associated with stunning in the isolated rabbit heart.
本研究的目的是评估单剂量硝苯地平对离体兔心脏心肌顿抑的影响。将分离前1 - 4小时经单剂量20 mg硝苯地平预处理的兔心脏(硝苯地平组)与对照心脏进行比较,观察它们在经历15分钟全心缺血(37℃)后再灌注30分钟的反应。两个实验组的基线心脏收缩性相似。在对照组再灌注期结束时,左心室等容收缩期压力(LVDP)和 +dP/dtmax分别稳定在缺血前值的45±2%和48±2%;在硝苯地平组,LVDP稳定在63±6%,+dP/dtmax稳定在66±6%(相对于对照组,P < 0.05)。与对照组相比,硝苯地平组再灌注结束时左心室舒张末期压力(LVEDP)值显著降低(36.8±5.5 mmHg对53.4±3.9 mmHg,P < 0.05)。硝苯地平预处理减轻了对照组中观察到的早期舒张时间常数(tau)的损害(对照组Δtau = 55±10 ms;硝苯地平组Δtau = 29±5 ms,P < 0.05)。再灌注结束时,对照组组织ATP和磷酸肌酸(CP)水平分别为6.9±0.7和8.7±0.7 μmol/g干组织;在硝苯地平组,ATP和CP水平显著更高,分别为9.2±0.7和11.5±0.9 μmol/g干组织(P < 0.05)。与硝苯地平组(CK = 82±5 mU/ml和LDH = 41±2 mU/ml,P < 0.05)相比,对照组再灌注期间肌酸激酶(CK)和乳酸脱氢酶(LDH)泄漏显著更高(CK = 120±15 mU/ml和LDH = 60±8 mU/ml)。我们的结果表明,单剂量口服(20 mg)硝苯地平预处理可减轻离体兔心脏中与顿抑相关的收缩和舒张功能改变以及代谢损害。